Đang chuẩn bị liên kết để tải về tài liệu:
Stem cell Transplantation for Eradication of Minimal PAncreatic Cancer persisting after surgical Excision (STEM PACE Trial, ISRCTN47877138): Study protocol for a phase II study

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

Pancreatic cancer is the third most common cancer related cause of death. Even in the 15% of patients who are eligible for surgical resection the outlook is dismal with less than 10% of patients surviving after 5 years. |

TÀI LIỆU LIÊN QUAN

Limbal stem cell deficiency: special focus on tracking limbal stem cells

Study the application of public cord blood stem cell transplantation for Leukemia treatment (from 10-2016 to 9-2018)

Outcome and prospective factor analysis of high-dose therapy combined with autologous peripheral blood stem cell transplantation in patients with peripheral T-cell lymphomas

Risk of febrile neutropenia among patients with multiple myeloma or lymphoma who undergo inpatient versus outpatient autologous stem cell transplantation: A systematic review and meta-analysis

Kinetics of neutrophil engraftment in allogeneic stem cell transplantation

Early transplantation-related mortality after allogeneic hematopoietic cell transplantation in patients with acute leukemia

Gastric antral vascular ectasia in a pediatric patient with neuroblastoma who underwent tandem stem cell transplantation

Successful allogeneic peripheral blood stem cell transplantation for an aggressive variant of T-cell large granular-lymphocyte leukemia: A case report

Stem cell Transplantation for Eradication of Minimal PAncreatic Cancer persisting after surgical Excision (STEM PACE Trial, ISRCTN47877138): Study protocol for a phase II study

Innovations in Stem Cell Transplantation Edited by Taner Demirer
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.